Company / Total Debt
IONIS PHARMACEUTICALS INC Total Debt History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.8B
FY2025
5-year range
$1.2B / $1.8B
FY2022-FY2025
Trend
+44.6%
vs FY2024
Sector context
#23 of 83
Health Care
What the data says
At $1.8B, IONIS PHARMACEUTICALS INC's total debt ranks #61 of 83 in the Health Care sector. Increased from $1.3B to $1.8B over the past 2 years.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 3-year CAGR of +14.9%.
Increased from $1.3B to $1.8B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 83 in Health CareTop 72% of 83This company $1.8B Sector average $6.2B
▼
-70.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +14.9%, indicating consistent growth.
- In FY2025, total debt increased 44.6% year-over-year.
- Ranks #23 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | +44.6% |
| FY2024 | $1.3B | -4.2% |
| FY2023 | $1.3B | +9.6% |
| FY2022 | $1.2B | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026